Skip to main content

Wipe patient wet hand wipes Individually wrapped

Reference: TPS16
Type: Top Proven Switch
Start Date: 12 July 2019
Expiry Date: While stock lasts

(50gsm, 180x160mm, 100 per pack)

  • Primary NPC – VJT177
  • Comparable NPCVJT407
  • Price difference – 28%
  • Trusts already purchasing – 6
  • Contract – Skin Cleansing
University College London Hospitals NHS Foundation Trust moved to this product a number of months ago having sought approval from our Infection Control team and Clinical Products Review Group. The product is used widely and in conjunction with meal services for patients. We have been very happy with it since, no issues to report and are therefore happy to endorse its wider use across the NHS.Phil Adams-Howell, Clinical Procurement Lead
University College London Hospitals NHS Foundation Trust
‘Proven Switch’ definition: based on an alternative already adopted by some NHS Supply Chain customer(s), which offer the largest potential savings nationally (i.e. across all of NHS Supply Chain’s customers). Identified based on the purchase history of customers, where the sales have stopped on the primary product and then started on the identified alternative product. Forecasted savings have been calculated based on the band 1 price of the primary product (i.e. the products currently used by trusts) minus the band 1 price of the alternative product multiplied by the last 12 months actual quantity purchased where a switch has been detected (switch: where sales have stopped on the primary product and then started on the identified alternative product). Potential savings have been calculated based on the band 1 price of the primary product (i.e. the products currently used by trusts) minus the band 1 price of the alternative product multiplied by the last 12 months actual quantity purchased. ‘No of trusts purchasing comparable products’ refers to NHS Supply Chain customers who already purchase the alternative product, this does not reflect the number of trusts who have made the switch from the primary to the alternative product. Trusts should check with clinical teams that the alternative product is suitable for its dedicated use in each instance. All savings and prices correct at time of publication. Read More / Read Less… »